SCM
IART icon

Sio Capital Management’s Integra LifeSciences IART Stock Holding History

Sio Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-383,140
Closed -$3.61M – 77
2026
Q1 		$3.61M Buy
+383,140
New +$4.21M 0.52% 46
2024
Q2 		– Sell
-137,000
Closed -$4.86M – 54
2024
Q1 		$4.86M Buy
+137,000
New +$5.48M 1.45% 27

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Sio Capital Management's IART Position: Q2 2026 in Review

Sio Capital Management sold out of Integra LifeSciences (IART) in Q2 2026, closing a stake of 383,140 shares — an estimated $3.61M sold.

Sio Capital Management first reported a position in IART in Q1 2024 and held it in 2 quarters. The position peaked at $4.86M in Q1 2024. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Sio Capital Management reported no remaining Integra LifeSciences position as of Q2 2026 after selling out during the quarter.
  • Sio Capital Management sold 383,140 Integra LifeSciences shares in Q2 2026, an estimated $3.61M.
  • Sio Capital Management first reported a position in Integra LifeSciences in Q1 2024 and held it in 2 quarters.
  • Sio Capital Management's Integra LifeSciences position peaked at $4.86M in Q1 2024.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Sio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.